Democratic Sweep Sets Stage for More Pharma Oversight

Democrats won big Tuesday after campaigning on affordability and health-care costs. Policy experts expect them to build on existing drug-pricing policies, while markets remain unconvinced that policies will dramatically change pharmaceutical fortunes.